The global diphenhydramine market is expected to grow at a CAGR of 4.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing prevalence of allergic reactions and chronic diseases such as asthma, arthritis, and diabetes. The oral administration segment accounted for the largest share in the global diphenhydramine market in 2018 owing to its wide range of applications such as treatment for allergies, insomnia, Parkinson's disease, and motion sickness.
North America accounted for the largest share in the global diphenhydramine market in 2018 due to high prevalence rates of allergic reactions and chronic diseases such as asthma, arthritis, and diabetes among people residing there. Europe followed North America with a significant share owing to its large population base that suffers from these conditions. Asia Pacific is expected to witness significant growth during the forecast period due to increasing awareness about these conditions among people residing there coupled with rising disposable incomes which will lead them towards adopting newer treatments like drugs that are expensive but effective against these conditions.
Some Of The Growth Factors Of This Market:
- The global Diphenhydramine market is driven by factors such as increasing prevalence of allergic rhinitis and asthma, growing awareness about the benefits of Diphenhydramine in treating allergies and asthma, and increasing demand for over-the-counter drugs with antihistamine properties.
- Increasing prevalence of allergic rhinitis and asthma.
- Growing awareness about the benefits of Diphenhydramine in treating allergies and asthma.
- Increasing demand for over-the-counter drugs with antihistamine properties.
Industry Growth Insights published a new data on “Diphenhydramine Market”. The research report is titled “Diphenhydramine Market research by Types (Tablets, Injections, Cream Preparations), By Applications (Oral Administration, Intramuscular Injection, Topical, Others), By Players/Companies Shandong Xinhua Pharmaceutical Co Ltd, Johnson & Johnson, S.S. PHARMACHEM, King-Pharm, Merck KGaA, Armas Pharmaceuticals, Pfizer, Bayer”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Diphenhydramine Market Research Report
By Type
Tablets, Injections, Cream Preparations
By Application
Oral Administration, Intramuscular Injection, Topical, Others
By Companies
Shandong Xinhua Pharmaceutical Co Ltd, Johnson & Johnson, S.S. PHARMACHEM, King-Pharm, Merck KGaA, Armas Pharmaceuticals, Pfizer, Bayer
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Diphenhydramine Market Report Segments:
The global Diphenhydramine market is segmented on the basis of:
Types
Tablets, Injections, Cream Preparations
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Oral Administration, Intramuscular Injection, Topical, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Shandong Xinhua Pharmaceutical Co Ltd
- Johnson & Johnson
- S.S. PHARMACHEM
- King-Pharm
- Merck KGaA
- Armas Pharmaceuticals
- Pfizer
- Bayer
Highlights of The Diphenhydramine Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Injections
- Cream Preparations
- By Application:
- Oral Administration
- Intramuscular Injection
- Topical
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Diphenhydramine Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Diphenhydramine is an over-the-counter medication used to treat the symptoms of allergies, such as sneezing, watery eyes, and a runny nose. It is also used to relieve the symptoms of colds and flu. Diphenhydramine can be taken by mouth or injection.
Some of the major companies in the diphenhydramine market are Shandong Xinhua Pharmaceutical Co Ltd, Johnson & Johnson, S.S. PHARMACHEM, King-Pharm, Merck KGaA, Armas Pharmaceuticals, Pfizer, Bayer.
The diphenhydramine market is expected to register a CAGR of 4.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Diphenhydramine Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Diphenhydramine Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Diphenhydramine Market - Supply Chain
4.5. Global Diphenhydramine Market Forecast
4.5.1. Diphenhydramine Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Diphenhydramine Market Size (000 Units) and Y-o-Y Growth
4.5.3. Diphenhydramine Market Absolute $ Opportunity
5. Global Diphenhydramine Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Diphenhydramine Market Size and Volume Forecast by Type
5.3.1. Tablets
5.3.2. Injections
5.3.3. Cream Preparations
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Diphenhydramine Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Diphenhydramine Market Size and Volume Forecast by Application
6.3.1. Oral Administration
6.3.2. Intramuscular Injection
6.3.3. Topical
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Diphenhydramine Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Diphenhydramine Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Diphenhydramine Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Diphenhydramine Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Diphenhydramine Demand Share Forecast, 2019-2026
9. North America Diphenhydramine Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Diphenhydramine Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Diphenhydramine Market Size and Volume Forecast by Application
9.4.1. Oral Administration
9.4.2. Intramuscular Injection
9.4.3. Topical
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Diphenhydramine Market Size and Volume Forecast by Type
9.7.1. Tablets
9.7.2. Injections
9.7.3. Cream Preparations
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Diphenhydramine Demand Share Forecast, 2019-2026
10. Latin America Diphenhydramine Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Diphenhydramine Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Diphenhydramine Market Size and Volume Forecast by Application
10.4.1. Oral Administration
10.4.2. Intramuscular Injection
10.4.3. Topical
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Diphenhydramine Market Size and Volume Forecast by Type
10.7.1. Tablets
10.7.2. Injections
10.7.3. Cream Preparations
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Diphenhydramine Demand Share Forecast, 2019-2026
11. Europe Diphenhydramine Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Diphenhydramine Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Diphenhydramine Market Size and Volume Forecast by Application
11.4.1. Oral Administration
11.4.2. Intramuscular Injection
11.4.3. Topical
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Diphenhydramine Market Size and Volume Forecast by Type
11.7.1. Tablets
11.7.2. Injections
11.7.3. Cream Preparations
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
1110. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Diphenhydramine Demand Share, 2019-2026
12. Asia Pacific Diphenhydramine Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Diphenhydramine Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Diphenhydramine Market Size and Volume Forecast by Application
12.4.1. Oral Administration
12.4.2. Intramuscular Injection
12.4.3. Topical
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Diphenhydramine Market Size and Volume Forecast by Type
12.7.1. Tablets
12.7.2. Injections
12.7.3. Cream Preparations
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Diphenhydramine Demand Share, 2019-2026
13. Middle East & Africa Diphenhydramine Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Diphenhydramine Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Diphenhydramine Market Size and Volume Forecast by Application
13.4.1. Oral Administration
13.4.2. Intramuscular Injection
13.4.3. Topical
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Diphenhydramine Market Size and Volume Forecast by Type
13.7.1. Tablets
13.7.2. Injections
13.7.3. Cream Preparations
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Diphenhydramine Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Diphenhydramine Market: Market Share Analysis
14.2. Diphenhydramine Distributors and Customers
14.3. Diphenhydramine Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Shandong Xinhua Pharmaceutical Co Ltd
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Johnson & Johnson
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. S.S. PHARMACHEM
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. King-Pharm
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Merck KGaA
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Armas Pharmaceuticals
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pfizer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bayer
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
